Catalyst Wire Dossier Catalyst Wire Dossier

LPCN 1148

· Lipocine Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LPCN 1148, covering 2024-03-15 to 2024-03-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia [Phase 2]

See pricing